People
McKenzie Cato's expertise is assisting medical device, pharmaceutical, and other life science industry companies with pre- and post-market FDA regulatory topics. McKenzie helps companies in developing their regulatory strategy, preparing regulatory submissions, responding to FDA requests for information and data, drafting regulatory policies and procedures, and reviewing advertising and promotional materials. McKenzie also assists companies with FDA, DOJ, and DEA enforcement matters, regulatory due diligence, and state regulatory and licensing issues.
Juris Doctor, George Washington University Law School, honors
B.S. Chemistry, Georgetown University
District of Columbia
Pennsylvania
July 12, 2024
FDA Issues Updated Draft Guidance on Addressing Misinformation About Medical Devices and Prescription Drugs
July 5, 2024
The LDT Final Rule Goes Into Effect Today
April 30, 2024
LDT Final Rule: Shifting the LDT Battlefield
July 12, 2024
FDA Issues Updated Draft Guidance on Addressing Misinformation About Medical Devices and Prescription Drugs
July 5, 2024
The LDT Final Rule Goes Into Effect Today
April 30, 2024
LDT Final Rule: Shifting the LDT Battlefield
Juris Doctor, George Washington University Law School, honors
B.S. Chemistry, Georgetown University
District of Columbia
Pennsylvania